BridgeMD
New treatment option for Radiation Exposure
Official title Comparison of Operator Radiation Exposure During Percutaneous Coronary Intervention Between Left Distal and Right Conventional Radial Access
ClinicalTrials.gov ID: NCT07579169
What this study is testing
- What it's testing
- This study aims to compare the operator's radiation exposure between left distal radial access (LDRA) and right transradial access (RTRA) in patients undergoing percutaneous coronary intervention (PCI).
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 and older
You may be able to join if
- Patients aged 19 years or older
- Patients scheduled for PCI
You likely can't join if
- Non-palpable left distal radial artery pulse
- Non-palpable right radial artery pulse
- Presence of arteriovenous fistula
- Need for femoral access as determined by the investigator
- Refusal to provide informed consent
- Pregnant or breastfeeding women
The study team makes the final eligibility decision.
Where it's taking place
- Osaka, Japan
- Yongin-si, Gyeonggi-do, South Korea
- Daegu, Gyeongsangnam-do, South Korea
- Jeonju, Jeollabuk-do, South Korea
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 20 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Osaka, Japan; Yongin-si, Gyeonggi-do, South Korea; Daegu, Gyeongsangnam-do, South Korea; Jeonju, Jeollabuk-do, South Korea. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.